Top compounds associated with response to TSPY2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA SB-525334 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Imatinib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.022 0.5
mRNA pluripotin CTRPv2 pan-cancer AAC -0.023 0.5
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.049 0.5
mRNA L-685458 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.027 0.5
Download CSV